Top Abstract Purchase Related
Home
>
Node
>
Subnode

In vitro immunosuppressive activities of recently developed anthracycline cytostatics

van der Nat, J.M.; Beijnen, J.H.; Driebergen, R.J.; Thart, L.A.; van Dijk, H.; Underberg, W.J.; Labadie, R.P.

Anticancer Research 8(3): 489-493

1988

ISSN/ISBN: 0250-7005
PMID: 3291748
Document Number: 308874
The effects of a series of seven anthracycline cytostatics on various human leukocyte functions, namely the production of Migration Inhibition Factor (MIF) by lymphocytes and the production of chemiluminescence by activated polymorphonuclear leukocytes (PMNs), as well as on classical and alternative pathways of activation of human complement were investigated. In addition, lipophilic and electrochemical properties of the compounds were determined, by measuring their High Performance Liquid Chromatography (HPLC) capacity ratio (k') and half - wave reduction potential (E1/2). The antitumor agents under investigation suppressed, in most cases, lymphocyte and PMN functions, whereas complement activity remained unaffected. The extent of suppressive effects showed a good correlation with the lipophilicity of the compounds, while no correlation with reduction potentials was found.

Document emailed within 1 workday
Secure & encrypted payments

Beijnen, J.H.; Van der Nat, J.M.; Labadie, R.P.; Underberg, W.J. 1986: Decomposition of mitomycin and anthracycline cytostatics in cell culture media Anticancer Research 6(1): 39-43
Zeevi, A.; Woan, M.; Yao, G.Z.; Venkataramanan, R.; Todo, S.; Starzl, T.E.; Duquesnoy, R.J. 1991: Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin Transplantation Proceedings 23(6): 2928-2930
Neyts, J.; Andrei, G.; De Clercq, E. 1998: The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo Antimicrobial Agents and ChemoTherapy 42(2): 216-222
Schuppli, R. 1970: Treatment of dermatologic lesions using immunosuppressive agents and cytostatics Münchener Medizinische Wochenschrift 112(12): 526-530
Mitrou, P.S.; Fischer, M.; Mitrou, G. 1976: Oncogenesis due to immunosuppressive agents (cytostatics) in (NZBxNZW) mice Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1729-1731
Lagrue, G.; Bariéty, J. 1970: Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents) Münchener Medizinische Wochenschrift 112(12): 515-522
Scherf, H.R.; Krüger, C.; Karsten, C. 1970: Studies in rats on immunosuppressive properties of cytostatics with special consideration of carcinogenic effect Arzneimittel-Forschung 20(10): 1467-1470
Schmitt, E.; Kröger, E.; Lakner, V.; Klinkmann, H.; Ratner, M.; Tomilina, N. 1979: Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(17): 465-471
Hecker, D.; Rose, H.; Powitz, A. 1978: The correlation of in vivo and in vitro effect of cytostatics in transplantated tumours of the mouse Acta Histochemica 62(1): 95-109
Studzian, K.; Wasowska, M.; Piestrzeniewicz, M.K.; Wilmańska, D.; Szmigiero, L.; Oszczapowicz, I.; Gniazdowski, M. 2001: Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics Neoplasma 48(5): 412-418
Emamgholipour Sefiddashti, S.; Homaie Rad, E.; Arab, M.; Bordbar, S. 2016: Female Labor Supply and Fertility in Iran: a Comparison Between Developed, Semi Developed and Less Developed Regions Iranian Journal of Public Health 45(2): 186-193
Ling, Y.H.; Priebe, W.; Yang, L.Y.; Burke, T.G.; Pommier, Y.; Perez-Soler, R. 1993: In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes Cancer Research 53(7): 1583-1589
Deguchi, K.; Koguchi, M.; Suzuki, Y.; Tanaka, S.; Fukayama, S.; Ishihara, R.; Oda, S. 1996: Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus Japanese Journal of Antibiotics 49(2): 194-202
Jonadet, M.; Meunier, M.T.; Bastide, J.; Bastide, P. 1983: Anthocyanosides extracted from Vitis vinifera, Vaccinium myrtillus and Pinus maritimus. I. Elastase-inhibiting activities in vitro. II. Compared angioprotective activities in vivo Journal de Pharmacie de Belgique 38(1): 41-46
Tomikawa, S.; Beck, Y.; Watanabe, K.; Kikuchi, K.; Ito, S.; Ando, Y.; Ichikawa, N.; Meigata, K.; Nomura, Y.; Degawa, H.; Nagao, T.; Uchida, H. 1996: Immunosuppressive effects of bactobolamine in vitro and in vivo Transplantation Proceedings 28(2): 1049-1051
Ward, M.; Lazda, V.A.; Gaddis, P.J.; Stormoen, B.M.; Smith, Y.; Fabrega, A.J.; Pollak, R. 1993: In vitro response to immunosuppressive agents in blacks Transplantation Proceedings 25(4): 2470-2471
Christians, U.; Sattler, M.; Schiebel, H.M.; Kruse, C.; Radeke, H.H.; Linck, A.; Sewing, K.F. 1992: Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycin Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(2): 186-191
Bladou, F.; Gleave, M.E.; Penault-Llorca, F.; Serment, G.; Lange, P.H.; Vessella, R.L. 1997: In vitro and in vivo models developed from human prostatic cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(3): 384-396
Gill, P.G.; Venables, W.; Ludbrook, J. 1971: Prediction of immunosuppressive potency of antilymphocyte serum by in vitro testing Journal of Immunology 107(1): 244-251
Anderson, D.J.; Tarter, T.H. 1982: Immunosuppressive effects of mouse seminal plasma components in vivo and in vitro Journal of Immunology 128(2): 535-539